CN115444804B - 一种山茶油面霜及其制备方法 - Google Patents
一种山茶油面霜及其制备方法 Download PDFInfo
- Publication number
- CN115444804B CN115444804B CN202211135879.1A CN202211135879A CN115444804B CN 115444804 B CN115444804 B CN 115444804B CN 202211135879 A CN202211135879 A CN 202211135879A CN 115444804 B CN115444804 B CN 115444804B
- Authority
- CN
- China
- Prior art keywords
- component
- cream
- mass ratio
- camellia oil
- follows
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006071 cream Substances 0.000 title claims abstract description 127
- 239000010495 camellia oil Substances 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 44
- 239000002994 raw material Substances 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 30
- 238000004321 preservation Methods 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 16
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 16
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 16
- 238000004945 emulsification Methods 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- 240000001548 Camellia japonica Species 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- 235000018597 common camellia Nutrition 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 9
- 229920001661 Chitosan Polymers 0.000 claims description 9
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 9
- 238000000265 homogenisation Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 8
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 8
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 8
- 229960000458 allantoin Drugs 0.000 claims description 8
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 8
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 8
- 229960005150 glycerol Drugs 0.000 claims description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 8
- 229960002216 methylparaben Drugs 0.000 claims description 8
- 239000002480 mineral oil Substances 0.000 claims description 8
- 235000010446 mineral oil Nutrition 0.000 claims description 8
- 229960005323 phenoxyethanol Drugs 0.000 claims description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 8
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 8
- -1 polydimethylsiloxane Polymers 0.000 claims description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 8
- 229960003415 propylparaben Drugs 0.000 claims description 8
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 8
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 8
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 8
- 239000000230 xanthan gum Substances 0.000 claims description 8
- 229920001285 xanthan gum Polymers 0.000 claims description 8
- 229940082509 xanthan gum Drugs 0.000 claims description 8
- 235000010493 xanthan gum Nutrition 0.000 claims description 8
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 7
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 7
- 244000080208 Canella winterana Species 0.000 claims description 6
- 235000008499 Canella winterana Nutrition 0.000 claims description 6
- 240000000902 Diospyros discolor Species 0.000 claims description 6
- 235000003115 Diospyros discolor Nutrition 0.000 claims description 6
- 229940017545 cinnamon bark Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims description 6
- 244000042664 Matricaria chamomilla Species 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 3
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 3
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims description 3
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- 229940057910 shea butter Drugs 0.000 claims description 2
- 244000151018 Maranta arundinacea Species 0.000 claims 1
- 235000010804 Maranta arundinacea Nutrition 0.000 claims 1
- 235000012419 Thalia geniculata Nutrition 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 10
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 5
- 239000003921 oil Substances 0.000 abstract description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 4
- 235000013824 polyphenols Nutrition 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 4
- 241001122767 Theaceae Species 0.000 abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 3
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 229930003231 vitamin Natural products 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 239000011782 vitamin Substances 0.000 abstract description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract description 2
- 239000005642 Oleic acid Substances 0.000 abstract description 2
- 206010070834 Sensitisation Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000019522 cellular metabolic process Effects 0.000 abstract description 2
- 230000000875 corresponding effect Effects 0.000 abstract description 2
- 238000005536 corrosion prevention Methods 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract description 2
- 230000008313 sensitization Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 24
- 230000003020 moisturizing effect Effects 0.000 description 19
- 238000012360 testing method Methods 0.000 description 15
- 238000013112 stability test Methods 0.000 description 12
- 230000001153 anti-wrinkle effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 238000011056 performance test Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 3
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OJCFEGKCRWEVSN-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO OJCFEGKCRWEVSN-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- 235000006467 Camellia japonica Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 description 1
- 240000002134 Pentadesma butyracea Species 0.000 description 1
- 235000000857 Pentadesma butyracea Nutrition 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000006103 coloring component Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
本发明属于化妆品技术领域,公开了一种山茶油面霜及其制备方法。所述山茶油面霜中,含有山茶油组分,山茶油富含油酸、亚油酸、茶多酚和维生素等多种组分,可以补充皮肤水分油分维持水油平衡、滋润修复皮肤、抑制自由基生成、促进细胞新陈代谢、预防和修复紫外线损伤、改善皮肤干燥老化、抗皱增强细胞活力、促进血液循环等。通过优化工艺和配方使山茶油的添加量增加,使的面霜中山茶油有足够的浓度从而起到相应的功效。同时通过使用消毒和添加防腐等组分,使面霜稳定性提高,便于储存和运输。而且本配方中无添加对皮肤刺激性的成分,主要成分为各种植物提取物,对消费者无致敏或致毒等不良反应。
Description
技术领域
本发明属于化妆品技术领域,特别涉及一种山茶油面霜及其制备方法。
背景技术
目前以面霜为主的化妆品占人们的消费比重越来越大,主要是因为它具有普适性特点,可以实现美白、抗氧化、抗皱等功效,受到广大消费者的喜爱,可以满足大多数人的皮肤需求,山茶油又称为茶树油,茶籽油。山茶油富含不饱和脂肪酸,且不含黄曲霉素等有毒成分,不饱和脂肪酸可以作为促透剂使化妆品中的功效分子增加透皮率,而且山茶油中富含极性多酚类和角鲨烯等物质,使其具有抗强氧化的性能,山茶油也含有氨基酸、维生素、茶多酚等功效成分,具有滋润皮肤、改善皮肤干燥和抗皱等多种功效,因为其优异的性能山茶油越来越多的用到面霜产品中。
传统面霜考虑到山茶油特有的性能,但忽视了一款好的面霜产品,需要与多种组分配合使用,而且山茶油本身也存在储存和抑菌问题,例如山茶油中富含不饱和双键,本身容易氧化,如果不加以保护,会在储存和运输中变质失活,因此需要对配方和制备工艺进行优化,以开发安全、温和、稳定以及持续皮肤护理作用的面霜产品。
发明内容
为了克服上述现有技术的缺点与不足,本发明的首要目的在于提供一种山茶油面霜。所述面霜对皮肤具有多种功效,而且分别在0℃、4℃、室温、45℃和55℃条件下存放10周,无气味和分层现象出现,表现出良好的稳定性。
本发明另一目的在于提供上述山茶油面霜的制备方法。
本发明的目的通过下述方案实现:
一种山茶油面霜,所述的面霜中包括组分A、组分B、组分C、组分D、组分E、组分F和组分G;在所述面霜中,组分A质量占比50-80%,组分B质量占比0.2-0.8%,组分C质量占比5-10%,组分D质量占比7-12%,组分E质量占比0.8-1.3%,组分F质量占比3-7%,组分G质量占比0-5%。
优选地,所述配方中组分A质量占比75-80%,组分B质量占比0.3-0.5%,组分C质量占比6-9%,组分D质量占比8-10%,组分E质量占比0.9-1.1%,组分F质量占比3.5-5%,组分G质量占比0.01-0.2%,此时山茶油面霜的使用效果较好。
所述组分A中包括定型、保湿、悬浮、增稠、附着、润滑、杀菌防腐的组分。
所述组分A中包括水、黄原胶、羟苯甲酯、透明质酸钠、尿囊素、甘油和丙二醇。
所述组分A中,各组分在面霜中的质量占比具体如下:水60~75%,黄原胶0.01~0.2%,羟苯甲酯0.05~0.5%,透明质酸钠0.005~0.08%,尿囊素0.03~0.4%,甘油2~10%,丙二醇1~6%。
优选地,在所述组分A中,各组分在面霜中的质量占比具体如下:水67~73%,黄原胶0.03~0.07%,羟苯甲酯0.1~0.3%,透明质酸钠0.01~0.05%,尿囊素0.05~0.2%,甘油3~5%,丙二醇1~5%。
更优选地,在所述组分A中,各组分在面霜中的质量占比具体如下:水68.838%,黄原胶0.05%,羟苯甲酯0.15%,透明质酸钠0.03%,尿囊素0.1%,甘油5%,丙二醇3%。
所述组分B中包括调节酸碱度的组分。
所述组分B中包括氢氧化钠和水。
所述组份B中,各组分在面霜中的质量占比具体如下:氢氧化钠0.01~0.2%和水0.2~0.6%。
优选地,在所述组分B中,各组分在面霜中的质量占比具体如下:氢氧化钠0.03~0.1%和水0.4~0.5%。
更优选地,在所述组份B中,各组分在面霜中的质量占比具体如下:氢氧化钠0.042%和水0.42%。
所述组分C中包括乳化,柔润、表面活化、保湿、分散、透气和防尘的组分。
所述组分C中包括醇磷酸酯、甘油硬脂酸酯、鲸蜡硬脂醇、羟苯丙酯和聚二甲基硅氧烷;优选地,所述醇磷酸酯为C20-C22醇磷酸酯。
在所述组份C中,各组分在面霜中的质量占比具体如下:醇磷酸酯0.5~3%、甘油硬脂酸酯0.01~1%、鲸蜡硬脂醇3~6%、羟苯丙酯0.01~1%和聚二甲基硅氧烷1~3%。
优选地,在所述组份C中,各组分在面霜中的质量占比具体如下:醇磷酸酯1~2%、甘油硬脂酸酯0.2~0.6%、鲸蜡硬脂醇3.5~4.5%、羟苯丙酯0.03~0.06%和聚二甲基硅氧烷1.5~2.5%。
更优选地,在所述组份C中,各组分在面霜中的质量占比具体如下:C20-C22醇磷酸酯1.3%、甘油硬脂酸酯0.5%、鲸蜡硬脂醇4%、羟苯丙酯0.05%和聚二甲基硅氧烷2%。
所述组分D中包括抗氧化、滋养修复皮肤、保湿和抗皱的组分,且其中包括山茶籽油。
所述组分D中包括山茶籽油、牛油果树果脂和生育酚乙酸酯。
在所述组份D中,各组分在面霜中的质量占比具体如下:山茶籽油6~10%、牛油果树果脂0.5~2%和生育酚乙酸酯0.1~1%。
优选地,在所述组份D中,各组分在面霜中的质量占比具体如下:山茶籽油7~9%、牛油果树果脂0.8~1.5%和生育酚乙酸酯0.2~0.5%。
更优选地,在所述组份D中,各组分在面霜中的质量占比具体如下:山茶籽油8%、牛油果树果脂1%和生育酚乙酸酯0.3%。
所述组分E中包括粘结、乳化和锁水的组分。
所述组分E中包括聚丙烯酸钠、矿油和月桂醇聚醚;优选地,所述月桂醇聚醚为月桂醇聚醚-6。
在所述组份E中,各组分在面霜中的质量占比具体如下:聚丙烯酸钠0~2%、矿油0~2%和月桂醇聚醚0~2%。
优选地,在所述组份E中,各组分在面霜中的质量占比具体如下:聚丙烯酸钠0~1%、矿油0~1%和月桂醇聚醚0~1%。
更优选地,在所述组份E中,各组分在面霜中的质量占比具体如下:聚丙烯酸钠0.3%、矿油0.3%和月桂醇聚醚-6 0.4%。
组分F中包括保湿、防腐、肤感调节、增香、成膜、调理和营养组分。
所述组分F中包括乙基己基甘油,苯氧乙醇、香精、水解鳕科鱼皮蛋白、羧甲基脱乙酰壳多糖、水解珍珠,苦参提取物、母菊花提取物、迷迭香叶提取物、野葛根提取物和肉桂树皮提取物。
在所述组份F中,各组分在面霜中的质量占比具体如下:乙基己基甘油0~1%,苯氧乙醇0~1%、香精0.01~0.3%、水解鳕科鱼皮蛋白0~3%、羧甲基脱乙酰壳多糖0~3%、水解珍珠0~2%,苦参提取物0~2%、母菊花提取物0~2%、迷迭香叶提取物0~2%、野葛根提取物0~2%和肉桂树皮提取物0~2%。
优选地,在所述组份F中,各组分在面霜中的质量占比具体如下:乙基己基甘油0~0.5%,苯氧乙醇0~0.5%、香精0.05~0.1%、水解鳕科鱼皮蛋白0~2%、羧甲基脱乙酰壳多糖0~2%、水解珍珠0~1.6%,苦参提取物0~1.6%、母菊花提取物0~1.6%、迷迭香叶提取物0~1.6%、野葛根提取物0~1.6%和肉桂树皮提取物0~1.6%。
更优选地,在所述组份F中,各组分在面霜中的质量占比具体如下:乙基己基甘油0.15%,苯氧乙醇0.15%、香精0.08%、水解鳕科鱼皮蛋白1%、羧甲基脱乙酰壳多糖1%、水解珍珠0.3%,苦参提取物0.3%、母菊花提取物0.3%、迷迭香叶提取物0.3%、野葛根提取物0.2%和肉桂树皮提取物0.2%。
所述组分G中包括着色组分。
所述组分G中包括CI15985和水。
所述组份G中,各组分在面霜中的质量占比具体如下:CI15985 0.1~0.5%和水0.01~0.1%。
优选地,在所述组份G中,各组分在面霜中的质量占比具体如下:CI15985 0.10~0.25%和水0.05~0.09%。
更优选地,在所述组份G中,各组分在面霜中的质量占比具体如下:CI159850.16%和水0.08%。
所述山茶油面霜中,含有山茶油组分,山茶油富含油酸、亚油酸、茶多酚和维生素等多种组分,可以补充皮肤水分油分维持水油平衡、滋润修复皮肤、抑制自由基生成、促进细胞新陈代谢、预防和修复紫外线损伤、改善皮肤干燥老化、抗皱增强细胞活力、促进血液循环等。因为山茶油本身具有稳定性差和易变质等问题,我们针对性地添加某些功效成分,例如分散、乳化和防腐等组分,与山茶油配合使用,达到使用和储存较全面有效的效果。
一种上述的山茶油面霜的制备方法,包括以下步骤:
1)将G相各组分混合,充分搅拌至粉体完全溶解均匀,备用;
2)将组分A中各原料混合并加热至50-90℃,均质至完全均匀后,再在保温条件下加入预先混溶透明的B相充分搅拌均匀,保温消泡备用;
3)将C相各原料混合并加热到50-90℃,搅拌至完全熔为液体,乳化前加入D相各原料,保温条件下充分搅拌至完全均匀,保温,备用;
4)真空且保温条件下,向步骤2)A+B相中加入步骤3)的C+D相,均质至完全乳化均匀,保温消泡后开始降温;
5)降温到40-80℃,加入E相各组分,保温条件下均质至完全均匀;
6)降温到25-55℃,加入F相各组分,真空下保温搅拌至完全均匀;
7)保温条件下加入G相改善面霜颜色;
步骤2)中所述的均质完全是指在50-90℃以1000-8000rpm的速度均质1-10min至完全均匀,优选为在75-85℃以1000-8000rpm的速度均质4-8min至完全均匀;
步骤2)中所述的保温的时间为5-25min,优选为10-20min。
步骤3)中加热至50-90℃优选为加热至70-85℃。
步骤4)中均质是指在8000-12000rpm的速度下均质1-15min至完全混合均匀,优选为5-10min。
步骤5)中所述的降温优选为降温至60-75℃;步骤5)中所述的保温均质是指在8000-12000rpm的速度下均质1-10min至完全均匀,优选为1-5min。
步骤6)中所述的降温优选为降温至30-45℃。
本发明相对于现有技术,具有如下的优点及有益效果:
本发明所述的山茶油面霜,通过制备工艺和配方的控制,香气怡人,提升了山茶籽油面霜的气味,膏体颜色呈淡黄色、膏体细腻,改善了山茶籽油淡流动性强和淡黄色缺点,与其它功效组分协同,均匀涂布能立即被吸收,使皮肤表面光滑透亮,通过优化工艺和配方使山茶油的添加量增加,使的面霜中山茶油有足够的浓度从而起到相应的功效。同时通过使用消毒和添加防腐等组分,使面霜稳定性提高,便于储存和运输。而且本配方中无添加对皮肤刺激性的成分,主要成分为各种植物提取物,对消费者无致敏或致毒等不良反应。
具体实施方式
下面结合实施例对本发明作进一步详细的描述,但本发明的实施方式不限于此。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
实施例中,山茶(CAMELLIA JAPONICA)籽油、水解鳕科鱼皮蛋白、羧甲基脱乙酰壳多糖、水解珍珠、苦参(SOPHORA FLAVESCENS)提取物、母菊(CHAMOMILLARECUTITA)花提取物、迷迭香(ROSMARINUS OFFICINALIS)叶提取物、野葛(PUERARIA LOBATA)根提取物、肉桂(CINNAMOMUM CASSIA)树皮提取物的供应商/生产商均为润普森。牛油果树(BUTYROSPERMUMPARKII)果脂的供应商/生产商为淼森。
除另有说明外,本发明中的百分比均均为质量百分比。
实施例1-4中山茶油面霜的配方具体如下表1所示:
表1实施例1-4中山茶油面霜的配方
实施例1
本实施例的一种含山茶油护面霜的配方及制备方法,按重量百分数配比如下:组分A质量占比75.36%,组分B质量占比0.378%,组分C质量占比7.93%,组分D质量占比10.05%,组分E质量占比0.89%,组分F质量占比4.245%,组分G质量占比1.147%。
操作步骤:1)将G相各组分混合,充分搅拌至粉体完全溶解均匀,备用;2)将组分A中各原料混合并加热至90℃,在4000rpm的速度下均质10min至完全均匀,再在保温条件下加入预先混溶透明的B相,充分搅拌均匀,保温15min消泡,备用;3)将C相各原料混合并加热到90℃搅拌至完全熔为液体,并在乳化前加入D相各原料,保温条件下充分搅拌至完全均匀,保温,备用;4)真空且保温条件下,向步骤2)A+B相中加入步骤3)的C+D相,在10000rpm的速度下均质15min至完全乳化均匀,保温20min消泡后开始降温;5)降温至80℃,加入E相各组分,以10000rpm的速度均质10min至完全均匀;6)降温至55℃,加入F相各组分,真空下搅拌至完全均匀;7)加入G相混合均匀以改善面霜颜色。
本实施例制得的面霜保湿性能测试、稳定性测试和抗皱测试在表格3-9中展现。
实施例2
本实施例的一种含山茶油护面霜的配方及制备方法,按重量百分数配比如下:组分A质量占比77.168%,组分B质量占比0.462%,组分C质量占比7.85%,组分D质量占比9.30%,组分E质量占比1.00%,组分F质量占比3.98%,组分G质量占比0.24%。
操作步骤:1)将G相各组分混合,充分搅拌至粉体完全溶解均匀,备用;2)将组分A中各原料混合并加热至85℃,在4000rpm的速度下均质8min至完全均匀,再在保温条件下加入预先混溶透明的B相,充分搅拌均匀,保温10min消毒消泡,备用;3)将C相各原料混合并加热到80℃搅拌至完全熔为液体,并在乳化前加入D相各原料,保温条件下充分搅拌至完全均匀,保温,备用;4)真空且保温条件下,向步骤2)A+B相中加入步骤3)的C+D相,在10000rpm的速度下均质8min至完全乳化均匀,保温15min消泡后开始降温;5)降温至75℃,加入E相各组分,以10000rpm的速度均质3min至完全均匀;6)降温至45℃,加入F相各组分,真空下搅拌至完全均匀;7)加入G相混合均匀以改善面霜颜色。
本实施例制得的面霜保湿性能测试、稳定性测试和抗皱测试在表格3-9中展现。
实施例3
本实施例的一种含山茶油护面霜的配方及制备方法,按重量百分数配比如下:组分A质量占比79.27%,组分B质量占比0.531%,组分C质量占比6.51%,组分D质量占比8.698%,组分E质量占比1.12%,组分F质量占比3.371%,组分G质量占比0.50%。
操作步骤:1)将G相各组分混合,充分搅拌至粉体完全溶解均匀,备用;2)将组分A中各原料混合并加热至50℃,在4000rpm的速度下均质1min至完全均匀,再在保温条件下加入预先混溶透明的B相,充分搅拌均匀,保温至少5min消毒消泡,备用;3)将C相各原料混合并加热到50℃搅拌至完全熔为液体,并在乳化前加入D相各原料,保温条件下充分搅拌至完全均匀,保温,备用;4)真空且保温条件下,向步骤2)A+B相中加入步骤3)的C+D相,在10000rpm的速度下均质1min至完全乳化均匀,保温5min消泡后开始降温;5)降温至40℃,加入E相各组分,以10000rpm的速度均质1min至完全均匀;6)降温至25℃,加入F相各组分,真空下搅拌至完全均匀;7)加入G相混合均匀以改善面霜颜色。
本实施例制得的面霜保湿性能测试、稳定性测试和抗皱测试在表格3-9中展现。
实施例4
本实施例的一种含山茶油护面霜的配方及制备方法,按重量百分数配比如下:组分A质量占比80.13%,组分B质量占比0.31%,组分C质量占比8.16%,组分D质量占比7.87%,组分E质量占比0.77%,组分F质量占比2.53%,组分G质量占比0.23%。
操作步骤:1)将G相各组分混合,充分搅拌至粉体完全溶解均匀,备用;2)将组分A中各原料混合并加热至60℃,在4000rpm的速度下均质3min至完全均匀,再在保温条件下加入预先混溶透明的B相,充分搅拌均匀,保温20min消毒消泡,备用;3)将C相各原料混合并加热到70℃搅拌至完全熔为液体,并在乳化前加入D相各原料,保温条件下充分搅拌至完全均匀,保温,备用;4)真空且保温条件下,向步骤2)A+B相中加入步骤3)的C+D相,在10000rpm的速度下均质4min至完全乳化均匀,保温8min消泡后开始降温;5)降温至65℃,加入E相各组分,以10000rpm的速度均质2min至完全均匀;6)降温至30℃,加入F相各组分,真空下搅拌至完全均匀;7)加入G相混合均匀以改善面霜颜色。
本实施例制得的面霜保湿性能测试、稳定性测试和抗皱测试在表格3-9中展现。
对比例1-2中山茶油面霜的配方具体如下表2所示:
表2对比例1-2中山茶油面霜的配方
对比例1
本对比例的一种含山茶油护面霜的配方及制备方法,按重量百分数配比如下:组分A质量占比80.168%,组分B质量占比0.462%,组分C质量占比7.85%,组分D质量占比6.30%,组分E质量占比1.00%,组分F质量占比3.98%,组分G质量占比0.24%。
所述对比例1中相对于实施例2减小了山茶油有效组分的添加量。
对比例1的制备方法与实施例2相同。
本对比例制得的面霜保湿性能测试和抗皱测试在表格3-9中展现。
对比例2
本对比例的一种含山茶油护面霜的配方及制备方法,按重量百分数配比如下:组分A质量占比74.168%,组分B质量占比0.462%,组分C质量占比7.85%,组分D质量占比12.3%,组分E质量占比1.00%,组分F质量占比3.98%,组分G质量占比0.24%。
所述对比例2中相对于实施例2增加了山茶油有效组分的添加量。
对比例2的制备方法与实施例2相同。
本对比例制得的面霜保湿性能测试和抗皱测试在表格3-9中展现。
保湿性测试
依据《QB/T 4256-2011化妆品保湿功效评价指南》测试本申请中的实施例1-4和对比例1-2制备得到的组合物的保湿效果。
测试所用仪器为皮肤弹性测试仪MPA580。测试所用样品为实施例1-4和对比例1-2制备得到的组合物。空白对照是指不使用任何样品。
实验步骤:筛选适合的受试者,清洁前臂内侧并标记测试区域。受试者在恒温恒湿条件下静坐20min,测量皮肤角质层水分含量、皮肤经皮水分流失量的初始值;按样品随机分布表分别在测试区域内涂抹(2.0±0.1)mg/cm2的待测样品。测量使用样品1、2、4、6小时后的皮肤角质层水分含量,利用软件SPSS19.0对数据进行统计分析。
皮肤角质层水分含量的变化率=(使用后皮肤角质层水分含量-使用前皮肤角质层水分含量)/使用前皮肤角质层水分含量×100%
测试结果如表3所示。
表3实施例1-4和对比例1-2的组合物在1、2、4、6小时后的皮肤角质层水分含量的变化率
样品 | 1h | 2h | 4h | 6h |
实施例1 | 44.50% | 33.58% | 28.71% | 24.92% |
实施例2 | 49.03% | 42.77% | 38.84% | 29.94% |
实施例3 | 47.25% | 37.01% | 33.02% | 25.66% |
实施例4 | 40.67% | 37.48% | 33.68% | 23.53% |
对比例1 | 30.83% | 21.88% | 18.87% | 13.64% |
对比例2 | 35.53% | 26.43% | 20.57% | 18.24% |
空白对照 | 0.45% | 1.99% | 0.69% | 0.84% |
如表3所示,实施例1-4和对比例1-2的面霜与空白对照相比,均表现出保湿效果,实施例1-4的面霜的保湿效果优于对比例1-2,实施例1-4和对比例1的面霜的保湿结果说明,低浓度山茶油不能起到很好的保湿效果;实施例1-4和对比例2的面霜的保湿结果说明,高浓度的山茶油影响了面霜其他组份的配比,降低了面霜的保湿效果。
稳定性测试
将实施例1-4和对比例2中的山茶油面霜装于无色透明的PE样品瓶中(每个样品重复3次),将样品瓶密封并分别放置于0℃、4℃、室温(25℃)、45℃、55℃的环境下,分别于第0周、第1周、第2周、第3周、第4周、第5周、第6周、第8周、第10周、测定山茶油面霜的颜色、气味、分层情况和pH值。
表4至表8为本申请实施例1~4和对比例2的山茶油面霜稳定性测试结果。
表4实施例1山茶油面霜稳定性测试结果
表5实施例2山茶油面霜稳定性测试结果
表6实施例3山茶油面霜稳定性测试结果
表7实施例4山茶油面霜稳定性测试结论
表8对比例2山茶油面霜稳定性测试结论
根据稳定性测试结果,对比例2中添加高含量的山茶油稳定性明显下降,实施例1-4的山茶油的添加量合适,山茶油面霜稳定性明显提升,可以长时间存放。
抗皱功效测试
测试方法:随机选取年龄在25-60岁,面部皱纹等级为1-3者的志愿者60名,男女不限,均分为6组(每一样品10个志愿者),分别使用实施例1-4以及对比例1-2中制备的山茶油面霜。具体使用方法如下:洁面后,用干燥手指取出面霜涂覆于面部,用水润湿面部,再用手指轻柔按摩至面霜完全吸收即可。志愿者自行连续使用2周,使用2周后开始问卷调查。
评定标准:显效-皮肤光滑富有弹性,皱纹明显淡化,小细纹消失;有效-皮肤较为光滑,弹性有所改善,小细纹明显淡化,但皱纹依然存在;无效-小细纹、皱纹依然存在,甚至有加深的趋势。
表9实施例1-4以及对比例1-2制备的山茶油面霜的抗皱效果对比
由表9所示,实施例1-4中,山茶油面霜可以达到优异抗皱效果。
由表3-9所示,实施例1-4中,山茶油面霜具备优异的保湿锁水性能,有明显的消除皱纹、平滑肌肤的效果。其中,实施例1和2的山茶油面霜的保湿效果最优。对比例1和2与实施例2相比,区别仅在于山茶油的加入量不同。上述抗皱功效测试的结果说明,山茶油的添加量影响了山茶油面霜的抗皱效果,在本发明中,山茶油的添加量应控制在6~10%。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (13)
1.一种山茶油面霜,其特征在于:
所述的面霜中包括组分A、组分B、组分C、组分D、组分E、组分F和组分G;
所述组分A中包括水、黄原胶、羟苯甲酯、透明质酸钠、尿囊素、甘油和丙二醇;
所述组分B中包括氢氧化钠和水;
所述组分C中包括醇磷酸酯、甘油硬脂酸酯、鲸蜡硬脂醇、羟苯丙酯和聚二甲基硅氧烷;
所述组分D中包括山茶籽油、牛油果树果脂和生育酚乙酸酯;
所述组分E中包括聚丙烯酸钠、矿油和月桂醇聚醚;
所述组分F中包括乙基己基甘油、苯氧乙醇、香精、水解鳕科鱼皮蛋白、羧甲基脱乙酰壳多糖、水解珍珠、苦参提取物、母菊花提取物、迷迭香叶提取物、野葛根提取物和肉桂树皮提取物;
所述组分G中包括CI15985和水;
所述组分A中,各组分在面霜中的质量占比为:水60~75%、黄原胶0.01~0.2%、羟苯甲酯0.05~0.3%、透明质酸钠0.005~0.08%、尿囊素 0.03~0.4%、甘油 2~10%、丙二醇 1~6%;
所述组分B中,各组分在面霜中的质量占比为:氢氧化钠0.01~0.2%和水0.2~0.6%;
所述组分G中,各组分在面霜中的质量占比为:CI15985 0.1~0.5%和水0.01~0.1%;
在所述组分C中,各组分在面霜中的质量占比为:醇磷酸酯0.5~3%、甘油硬脂酸酯0.01~1%、鲸蜡硬脂醇3~6%、羟苯丙酯0.01~0.06%和聚二甲基硅氧烷1~3%;
在所述组分D中,各组分在面霜中的质量占比为:山茶籽油6~10%、牛油果树果脂0.5~2%和生育酚乙酸酯0.1~1%;
在所述组分E中,各组分在面霜中的质量占比为:聚丙烯酸钠0.3~2%、矿油0.3~2%和月桂醇聚醚0.4~2%;
在所述组分F中,各组分在面霜中的质量占比为:乙基己基甘油0.15~1%、苯氧乙醇0.15~1%、香精0.01~0.3%、水解鳕科鱼皮蛋白1~3%、羧甲基脱乙酰壳多糖1~3%、水解珍珠0.3~2%,苦参提取物0.3~2%、母菊花提取物0.3~2%、迷迭香叶提取物0.3~2%、野葛根提取物0.2~2%和肉桂树皮提取物0.2~2%。
2.根据权利要求1所述的山茶油面霜,其特征在于:
所述组分A中,各组分在面霜中的质量占比具体如下:水67~73%、黄原胶0.03~0.07%、羟苯甲酯0.10~0.3%、透明质酸钠0.01~0.05%、尿囊素 0.05~0.2%、甘油 3~5%、丙二醇 1~5%。
3.根据权利要求2所述的山茶油面霜,其特征在于:
在所述组分A中,各组分在面霜中的质量占比具体如下:水68.838%、黄原胶0.05%、羟苯甲酯0.15%、透明质酸钠 0.03%、尿囊素0.1%、甘油5%、丙二醇3%。
4.根据权利要求1所述的山茶油面霜,其特征在于:
在所述组分C中,各组分在面霜中的质量占比具体如下:醇磷酸酯1~2%、甘油硬脂酸酯0.2~0.6%、鲸蜡硬脂醇3.5~4.5%、羟苯丙酯0.03~0.06%和聚二甲基硅氧烷1.5~2.5%。
5.根据权利要求4所述的山茶油面霜,其特征在于:
在所述组分C中,各组分在面霜中的质量占比具体如下:C20-C22醇磷酸酯1.3%、甘油硬脂酸酯0.5%、鲸蜡硬脂醇4%、羟苯丙酯0.05%和聚二甲基硅氧烷2%。
6.根据权利要求1所述的山茶油面霜,其特征在于:
在所述组分D中,各组分在面霜中的质量占比具体如下:山茶籽油7~9%、牛油果树果脂0.8~1.5%和生育酚乙酸酯0.2~0.5%。
7.根据权利要求6所述的山茶油面霜,其特征在于:
在所述组分D中,各组分在面霜中的质量占比具体如下:山茶籽油8%、牛油果树果脂1%和生育酚乙酸酯0.3%。
8.根据权利要求1所述的山茶油面霜,其特征在于:
在所述组分E中,各组分在面霜中的质量占比具体如下:聚丙烯酸钠0.3~1%、矿油0.3~1%和月桂醇聚醚0.4~1%。
9.根据权利要求8所述的山茶油面霜,其特征在于:
在所述组分E中,各组分在面霜中的质量占比具体如下:聚丙烯酸钠0.3%、矿油0.3%和月桂醇聚醚-6 0.4%。
10.根据权利要求1所述的山茶油面霜,其特征在于:
在所述组分F中,各组分在面霜中的质量占比具体如下:乙基己基甘油0.15~0.5%、苯氧乙醇0.15~0.5%、香精0.05~0.1%、水解鳕科鱼皮蛋白1~2%、羧甲基脱乙酰壳多糖1~2%、水解珍珠0.3~1.6%、苦参提取物0.3~1.6%、母菊花提取物0.3~1.6%、迷迭香叶提取物0.3~1.6%、野葛根提取物0.2~1.6%和肉桂树皮提取物0.2~1.6%。
11.根据权利要求10所述的山茶油面霜,其特征在于:
在所述组分F中,各组分在面霜中的质量占比具体如下:乙基己基甘油0.15%、苯氧乙醇0.15%、香精0.08%、水解鳕科鱼皮蛋白1%、羧甲基脱乙酰壳多糖1%、水解珍珠0.3%、苦参提取物0.3%、母菊花提取物0.3%、迷迭香叶提取物0.3%、野葛根提取物0.2%和肉桂树皮提取物0.2%。
12.一种根据权利要求1-11任一项所述的山茶油面霜的制备方法,其特征在于包括以下步骤:
1)将G相各组分混合,充分搅拌至粉体完全溶解均匀,备用;
2)将组分A中各原料混合并加热至50-90℃,均质至完全均匀后,再在保温条件下加入预先混溶透明的B相充分搅拌均匀,保温消泡备用;
3)将C相各原料混合并加热到50-90℃,搅拌至完全熔为液体,乳化前加入D相各原料,保温条件下充分搅拌至完全均匀,保温,备用;
4)真空且保温条件下,向步骤2)A+B相中加入步骤3)的C+D相,均质至完全乳化均匀,保温消泡后开始降温;
5)降温到40-80℃,加入E相各组分,保温条件下均质至完全均匀;
6)降温到25-55℃,加入F相各组分,真空下保温搅拌至完全均匀;
7)保温条件下加入G相改善面霜颜色。
13.根据权利要求12所述的山茶油面霜的制备方法,其特征在于:
步骤2)中所述的均质完全是指在50-90℃以1000-8000rpm的速度均质1-10min至完全均匀;
步骤4)中均质是指在8000-12000rpm的速度下均质1-15min至完全混合均匀;
步骤5)中所述的保温均质是指在8000-12000rpm的速度下均质1-10min至完全均匀。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211135879.1A CN115444804B (zh) | 2022-09-19 | 2022-09-19 | 一种山茶油面霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211135879.1A CN115444804B (zh) | 2022-09-19 | 2022-09-19 | 一种山茶油面霜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115444804A CN115444804A (zh) | 2022-12-09 |
CN115444804B true CN115444804B (zh) | 2024-05-07 |
Family
ID=84305346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211135879.1A Active CN115444804B (zh) | 2022-09-19 | 2022-09-19 | 一种山茶油面霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115444804B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108309831A (zh) * | 2018-03-21 | 2018-07-24 | 珠海美高美健康科技有限公司 | 含有山茶籽油的护肤霜及其制备方法 |
CN110507554A (zh) * | 2019-09-06 | 2019-11-29 | 王文概 | 一种含有山茶籽油的天然无添加保湿霜及其制备方法 |
CN111297712A (zh) * | 2020-03-13 | 2020-06-19 | 上海新高姿化妆品有限公司 | 一种面霜组合物及其制备方法 |
CN111557874A (zh) * | 2020-04-29 | 2020-08-21 | 上海清轩生物科技有限公司 | 一种仿生的、含山茶提取物的修复皮肤屏障组合物和应用 |
CN111658566A (zh) * | 2020-06-30 | 2020-09-15 | 广州市瑞芬化妆品有限公司 | 一种深层补水修复面部滋养霜及其制备方法 |
CN113057902A (zh) * | 2021-02-20 | 2021-07-02 | 仲恺农业工程学院 | 一种含水解植物蛋白的油茶籽油面霜及其制备方法 |
-
2022
- 2022-09-19 CN CN202211135879.1A patent/CN115444804B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108309831A (zh) * | 2018-03-21 | 2018-07-24 | 珠海美高美健康科技有限公司 | 含有山茶籽油的护肤霜及其制备方法 |
CN110507554A (zh) * | 2019-09-06 | 2019-11-29 | 王文概 | 一种含有山茶籽油的天然无添加保湿霜及其制备方法 |
CN111297712A (zh) * | 2020-03-13 | 2020-06-19 | 上海新高姿化妆品有限公司 | 一种面霜组合物及其制备方法 |
CN111557874A (zh) * | 2020-04-29 | 2020-08-21 | 上海清轩生物科技有限公司 | 一种仿生的、含山茶提取物的修复皮肤屏障组合物和应用 |
CN111658566A (zh) * | 2020-06-30 | 2020-09-15 | 广州市瑞芬化妆品有限公司 | 一种深层补水修复面部滋养霜及其制备方法 |
CN113057902A (zh) * | 2021-02-20 | 2021-07-02 | 仲恺农业工程学院 | 一种含水解植物蛋白的油茶籽油面霜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115444804A (zh) | 2022-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107468621B (zh) | 舒敏护肤乳液及其制备方法 | |
CN101889966B (zh) | 一种茶油防裂霜组合物的制备方法及制品 | |
CN109528595B (zh) | 一种植物护肤组合物及其制备方法 | |
CN108524305B (zh) | 一种儿童皮肤屏障修复保湿霜及其制备方法 | |
CN111568816A (zh) | 一种面霜及其制备方法 | |
CN110974771A (zh) | 一种头皮护理组合物及其应用 | |
CN111374924A (zh) | 一种婴儿小麦鲜萃原浆护臀膏及其制备方法 | |
CN112641694A (zh) | 一种美白精华乳及其制备方法 | |
CN110721120A (zh) | 一种多功能护肤膏及其制备方法 | |
CN114099387B (zh) | 一种玫瑰美白保湿精华乳及其制备方法 | |
CN114732761A (zh) | 一种紫草油滋养修护乳液及其制备方法 | |
CN111700851B (zh) | 一种舒缓保湿组合物及其制备方法与应用 | |
CN110279626A (zh) | 具有协同长效保湿效果的化妆品组合物及其制备方法 | |
CN112245315A (zh) | 一种具有保湿修复功效的神经酰胺面膜及其制备方法 | |
CN115444804B (zh) | 一种山茶油面霜及其制备方法 | |
CN112402354A (zh) | 一种滋润保湿乳及其制备方法 | |
CN112156058A (zh) | 婴幼儿保湿润肤乳及其制备方法 | |
CN108635272B (zh) | 一种修护眼霜及其制备方法 | |
CN106580821A (zh) | 减轻皮肤过敏发红的组合物及其在婴幼儿润肤乳中的应用 | |
CN105919886A (zh) | 一种速效修复皱纹的乳液及其制备方法 | |
CN103781477A (zh) | 包含3-丁氧基-1,2-丙二醇的抗菌或防腐组合物 | |
CN103006477A (zh) | 一种山茶油滋润霜 | |
CN107496286B (zh) | 一种淡化细纹补水滋润型水乳及其制备方法 | |
CN113230182B (zh) | 一种紧致修护面霜及其制备方法 | |
CN108703934A (zh) | 一种婴儿特护护臀霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |